Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriers
- 25 February 2013
- journal article
- research article
- Published by Wiley in Clinical Genetics
- Vol. 85 (1), 49-53
- https://doi.org/10.1111/cge.12130
Abstract
BRCA testing services are now offered by various healthcare providers, thus it is important to evaluate whether the implementation of cancer risk management (CRM) strategies varies by service provider. Using a registry‐based sample of 795 female BRCA mutation carriers, we explored the association between uptake of CRM strategies with duration of genetic counseling (GC) sessions, provider type, and other demographic and clinical variables. All participants completed a baseline questionnaire. Information about uptake of CRM strategies was collected for a subset of 438 participants who completed additional questions. Summary statistics and Pearson chi‐squared analysis were used to examine the associations between demographic and clinical variables with service delivery factors and with the uptake of various CRM strategies. Overall uptake of CRM strategies was high across all provider types. However, GC sessions were longer when provided by a genetics professional than by another provider (p < 0.001). Furthermore, higher frequencies of uptake of most CRM strategies were associated with longer GC sessions and when testing was performed by a genetics professional. Identification of factors to optimize delivery of these specialized GC services is important to maximize implementation of CRM strategies in BRCA carriers.Keywords
This publication has 12 references indexed in Scilit:
- Genetic Risk Assessments in Individuals at High Risk for Inherited Breast Cancer in the Breast Oncology Care SettingCancer Control, 2012
- Adverse Events in Cancer Genetic TestingThe Cancer Journal, 2012
- Essential Elements of Genetic Cancer Risk Assessment, Counseling, and Testing: Updated Recommendations of the National Society of Genetic CounselorsJournal of Genetic Counseling, 2011
- Genetics, genomics, and cancer risk assessmentCA: A Cancer Journal for Clinicians, 2011
- American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer SusceptibilityJournal of Clinical Oncology, 2010
- Physicians’ Experiences With BRCA1/2 Testing in Community SettingsJournal of Clinical Oncology, 2008
- Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physiciansJournal of Medical Genetics, 2005
- Prevention and Management of Hereditary Breast CancerJournal of Clinical Oncology, 2005
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1Science, 1994